Abstract:Background Genetic, clinical and experimental evidence has mounted to suggest the implication of gut dysbiosis in the pathogenesis of ankylosing spondylitis (AS) through the gut-joint axis of inflammation[1]. A series of cross-sectional studies have unraveled the alterations of gut microbiome composition in patients with AS using metagenome sequencing. However, such observational associations might be limited to the small sample sizes and the influences from confounders. Furthermore, whether gut dysbiosis is a cause or a consequence of AS remains elusive. Mendelian randomization (MR) is an epidemiologic approach for causal inference using genetic variants as instrument variables. Objectives To assess the causal relationship between gut bacteria taxa and risk of AS using two-sample MR. Methods To select instrument variables for gut bacteria taxa, we filtered genome-wide significant (p ≤ 5 x 10-8) and independent (r 2 < 0.01 within the window size of 500kb) variants for 211 taxa from a large-scale genome-wide association study (GWAS) on gut microbiota which included 18,340 individuals from 24 cohorts[2]. The summary statistics on AS from the UK Biobank (UKB) and the FinnGen consortium were utilized for the discovery and replication analyses, respectively[3]. Under the framework of two-sample MR, the inverse variance weighted method or the Wald ratio method was used to assess the causal effect of gut microbial taxa on risk of AS. In addition, multiple sensitivity analyses and reverse MR analyses were conducted to validate the robustness of results and evaluate reverse causation, respectively. Results Despite no taxa passing the multiple-testing correction, six known taxa were identified to have causal effects on the onset of AS in the UKB cohort at the nominal significance level (p < 0.05). In the FinnGen cohort, only one bacterial genus, Anaerotruncus was replicated (UKB: βIVW = -0.0016, p = 0.04; FinnGen: βIVW = -0.3990, p = 0.04). Sensitivity analyses led no support to the presence of heterogeneity (Q_p > 0.05) and pleiotropy (Intercept_p > 0.05). Reverse MR analysis found no reverse causality from AS to Anaerotruncus. Conclusion Despite no current evidence supporting the association between Anaerotruncus and AS, this study provides the first genetic evidence for the protective effect of this short-chain fatty acid (SCFA)-producer against AS. Intriguingly, several studies have suggested a relationship between Anaerotruncus and immune-mediated diseases including rheumatoid arthritis and inflammatory bowel diseases[4]. These MR findings shed light on the causative microbiota and microbiome-modulating strategies for AS. References [1]Qaiyum Z, Lim M, Inman RD. The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights. Semin Immunopathol 2021;43:173–92. doi:10.1007/s00281-021-00845-0 [2]Kurilshikov A, Medina-Gomez C, Bacigalupe R, et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet 2021;53:156–65. doi:10.1038/s41588-020-00763-1 [3]S S, M K, Y T, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet 2021;53. doi:10.1038/s41588-021-00931-x [4]Thomann AK, Wüstenberg T, Wirbel J, et al. Depression and fatigue in active IBD from a microbiome perspective-a Bayesian approach to faecal metagenomics. BMC Med 2022;20:366. doi:10.1186/s12916-022-02550-7 Acknowledgements We thank the researchers in the MiBioGen consortium, UK Biobank and FinnGen biobanks for releasing their valuable GWAS datasets. Disclosure of Interests None Declared.

AB0107 A CAUSAL EFFECT OF IL-10 LEVELS ON THE RISK OF ANKYLOSING SPONDYLITIS: A MENDELIAN RANDOMIZATION STUDY

AB0106 CAUSAL RELATIONSHIP BETWEEN IL-17 FAMILY MEMBERS AND THEIR RECEPTORS AND ANKYLOSING SPONDYLITIS: A TWO-SAMPLE MENDELIAN RANDOMIZATION STUDY

Therapeutic potential of single-nucleotide polymorphism-mediated IL6R inhibitors in ankylosing spondylitis treatment

Exploring causal correlations between inflammatory cytokines and ankylosing spondylitis: a bidirectional mendelian-randomization study

OP0028 Low Dose IL-2 Therapy Can Recovery TH17/TREG Cell Balance in Patients with Ankylosing Spondylitis

Causal relationship between the immune cells and ankylosing spondylitis: univariable, bidirectional, and multivariable Mendelian randomization

Association of IL-1 Gene Complex Members with Ankylosing Spondylitis in Chinese Han Population.

AB0088 GENETICALLY DETERMINED GUT MICROBIOME AND THE RISK OF ANKYLOSING SPONDYLOARTHRITIS

Pos0437 genetically determined telomere length and the risk of ankylosing spondylitis

AB0003 IL-23R and IL-17A Polymorphisms Correlate with Susceptibility of Ankylosing Spondylitis in Chinese Han Population

An ankylosing spondylitis-associated genetic variant in the IL23R-IL12RB2 intergenic region modulates enhancer activity and is associated with increased Th1-cell differentiation

CD96 Downregulation Promotes the Immune Response of CD4 T Cells and Associates with Ankylosing Spondylitis.

Evaluation of interleukins (IL-1α, IL-1Ra, IL-12, IL-17A, IL-31, and IL-33) and chemokines (CXCL10 and CXCL16) in the serum of male patients with ankylosing spondylitis

AB0988 GENETIC EVIDENCE FOR A BIDIRECTIONAL CAUSAL RELATIONSHIP BETWEEN ANKYLOSING SPONDYLITIS AND CARDIOVASCULAR DISEASE

Association of IL-1A and IL-1B polymorphisms with ankylosing spondylitis among the Chinese Han population: a case-control study.

AB0089 MENDELIAN RANDOMIZATION REVEALS CAUSATIVE GUT BACTERIA FOR ANKYLOSING SPONDYLITIS

The Effect of Single Nucleotide Polymorphism in Interleukin-1 Gene on the Susceptibility of Ankylosing Spondylitis in Chinese Han Population

Interleukin-23 receptor genetic polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis

Exploring the causal relationship between inflammatory cytokines and inflammatory arthritis: A Mendelian randomization study

Investigating potential novel therapeutic targets and biomarkers for ankylosing spondylitis using plasma protein screening

Mendelian randomization studies in ankylosing spondylitis: A systematic review